Preserve Patient Access to Reputable DMEPOS Providers Act of 2009

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

Client expense: $350,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Reconciliation Act of 2010 H.R. 616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R. 3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparancy, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S. 3532, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010.

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), pharmacy dispensing fees, privacy, drug safety, and reimportation. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. S 510 - The Food Safety Modernization Act HR 3108 - Medication Therapy Management Benefits Act of 2009 PL 111-148 - The Patient Protection and Affordable Care Act; provisions related to provider screening and documentation for referral of DME PL 111-152 - Health Care and Education Reconciliation Act; provisions related to provider screening and documentation for referral of DME Implementation of the Medicare Provider Enrollment, Chain and Ownership System (PECOS)

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

Client expense: $350,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

SBA Reauthorization, SBA Surety Bond Guarantee Program, Customs Bonds, surety bond requirements for suppliers of Durable Medical Equipment, Prosthetics, Orthotics and Supplies (HR 3200, HR 1970, HR 3663, S956 and S975), Miller Act thresholds, federal procurement issues (S2989), regulatory oversight of surface mining permits

Client expense: $10,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Surface Mining Reclamation & Enforcement, SENATE, Small Business Administration (SBA), U.S. Customs & Border Protection

HR 2718/S 1110 - MedPAC Reform Act of 2009 HR 2307/S 1004 - Reaching Elders with Assessment and Chronic Care Management and Coordination Act Under Line 17: We would like to include the Dept of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC) and the Office of Inspector General (OIG) S 1634 - The Medicare Prescription Drug Improvement Act of 2009 S 266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR 203 - Medicare Fraud Prevention Act of 2009 HR 27 - Medicare Fraud Prevention and Enforcement Act of 2009 HR 616/S 511 - Access to Durable Medical Equipment Act HR 574/S 254 - Medicare Home Infusion Therapy Coverage Act of 2009 HR 2560/S 1131 - Independence At Home Act HR 1970/S 956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR 3700/S 1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturers Price Reimbursement Formula in Health Care Reform HR 3108 - Medication Therapy Management Benefits Act of 2009/Concept to Include Medication Therapy Management Provisions in Health Care Reform S 683 - Community Choice Act of 2009 HR 1392/S 1221 - Amends the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price S AMDT 3320 to the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2010 (H.R.2847) [Section on the treatment of pharmacies under durable medical equipment accreditation requirements] (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 sections on Medicare DMEPOS (Docket Number CMS-4085-P) Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) (Docket Number: CMS-0033-P) Medicare and Medicaid Programs; Electronic Health Record Incentive Program; Proposed Rule (Docket Number: RIN 0991-AB58) Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (Docket Number: RIN 0991AB59) Proposed Establishment of Certification Programs for Health Information Technology (74 FR 28937) ONC Draft Recommendations for the Term "Meaningful Use" of Electronic Health Records CMS August 2009 Memo: Fraud, Waste and Abuse (FWA) Training Clarification (regarding changes to 42 C.F.R. 422.503(b)(4)(vi) and 42 C.F.R. 423.504 (b)(4)(vi)) Final 2010 Medicare Part D Call Letter on NDC Non-Matched List 2011 Preliminary Advanced Notice with Draft Call Letter to Medicare Plans 2011 Preliminary Advanced Notice with Final Call Letter to Medicare Plans Draft Medicare Part D Model Notices for Beneficiaries: Mail-Order and Excluded Provider GAO Report on Medicaid Outpatient Prescription Drugs: Second Quarter 2008 Federal Upper Limits for Reimbursement Compared with Average Retail Pharmacy Acquisition Costs OIG Report on A Comparison of Medicaid Federal Upper Limit Amounts to Acquisition Costs, Medicare Payment Amounts, and Retail Prices

Client expense: $149,615 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 110th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; and Sec. 172, related to submission of claims by pharmacies located in or contracting with long-term care facilities; Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements; H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009, pharmacy provider provisions; S. 1383, the "Dextromethorphan Abuse Reduction Act; H.R.3663: To amend title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies; H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy management, public plan option and pharmacy benefit manager transparency requirements; H.R.3590: An act entitled The Patient Protection and Affordable Care ActDME Accreditation, AMP Fix, PBM Transparency, MTM Expansion, OPM PBA v. PBM; Senator Akaka Amendment to Senate version of H.R. 3590 to establish automatic enrollment into a Medicare Part D "chronic care management" program for targeted individuals; Senator Brown amendment to H.R. 3590 eliminating DMEPOS surety bond requirement for retail pharmacies; Senator Dorgan Drug Reimportation amendment to H.R. 3590; FSA Debit Card Programseeking Congressional support to amend IRS guidance (no legislation). P.L. 110-275, the Medicare Improvements for Patients and Providers Act of 2008, implementation of Part D prompt payment and Part B DMEPOS provisions; H.R. 4213, American Workers, State, and Business Relief Act of 2010, section 213, Medicare Part B DMEPOS accreditation requirements; H.R. 4872 and substitute amendment to H.R. 4872, the Health Care and Education Affordability Reconciliation Act of 2010, section 1101, the Medicare Part D "donut hole", section 1305, oversight of DMEPOS suppliers.

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Treasury, Dept of

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), pharmacy dispensing fees, privacy, drug safety, and reimportation. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 3200: America's Affordable Health Choices Act of 2009 HR 3590: The Patient Protection and Affordable Care Act HR 3962: Affordable Health Care for America Act S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act of 2009 HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 3108 - Medication Therapy Management Benefits Act of 2009

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R.3590, Patient Protection and Affordable Care Act H.R.4872: Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemptionof pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exmpetion from Medicare Part B reguations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S. 1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221 Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and dislosure requirements in the FEHBP. S. 3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds.

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

H.R. 1548 & S. 1427 to amend title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes Average Manufacturers Price H.R. 616 & S. 511 to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals H.R. 1970 & S. 956 to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS)

Client expense: $2,030,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Energy, Dept of, Federal Energy Regulatory Commission (FERC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

IRS Regulation of tax preparers, SBA Reauthorization, SBA Surety Bond Guarantee Program, Department of Transportation program for small contractor mentoring, Customs Bonds, powers of attorney for federal surety bonds, surety bond requirements for suppliers of Durable Medical Equipment, Prosthetics, Orthotics and Supplies (HR 3200, HR 1970, HR 3663, S956 and S975), HR 3771 and HR 294, small business capital access.

Client expense: $10,000 · Firm income: Not reported

Government targets: Army, Dept of (Corps of Engineers), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

Client expense: $430,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

HR 2718/S 1110 - MedPAC Reform Act of 2009 HR 2307/S 1004 - Reaching Elders with Assessment and Chronic Care Management and Coordination Act S 1634 - The Medicare Prescription Drug Improvement Act of 2009 Under Line 17: We would like to include the Office of the National Coordinator for Health Information Technology S 266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR 203 - Medicare Fraud Prevention Act of 2009 HR 27 - Medicare Fraud Prevention and Enforcement Act of 2009 HR 616/S 511 - Access to Durable Medical Equipment Act HR 574/S 254 - Medicare Home Infusion Therapy Coverage Act of 2009 HR 2560/S 1131 - Independence At Home Act HR 1970/S 956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR 3700/S 1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturers Price Reimbursement Formula in Health Care Reform HR 3108 - Medication Therapy Managament Benefits Act of 2009/Concept to Include Medication Therapy Management Provisions in Health Care Reform HR 3663 - Amends the Social Security Act to delay the October 1, 2009 deadline on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies. (Public Law 111-72) S 683 - Community Choice Act of 2009 HR 1392/S 1221 - Amends the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 sections on Medicare DMEPOS (Docket Number CMS-4085-P) Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) (Docket No. CMS-4085-P) Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs Docket Number: CMS-10260 (OMB#: 0938-1051) Collection Activities; Medicare Advantage and Prescription Drug Program: Final Marketing Provisions (74 FR 28937) ONC Draft Recommendations for the Term "Meaningful Use" of Electronic Health Records CMS August 2009 Memo: Fraud, Waste and Abuse (FWA) Training Clarification (regarding changes to 42 C.F.R. 422.503(b)(4)(vi) and 42 C.F.R. 423.504 (b)(4)(vi)) Final 2010 Medicare Part D Call Letter Draft Part D Model Notices for Beneficiaries: Mail-Order and Excluded Provider

Client expense: $117,517 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 110th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; and Sec. 172, related to submission of claims by pharmacies located in or contracting with long-term care facilities; Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements; H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009, pharmacy provider provisions; S. 1383, the "Dextromethorphan Abuse Reduction Act; H.R.3763: To amend the Fair Credit Reporting Act to provide for an exclusion from Red Flag Guidelines for certain businesses, pharmacy provision; H.R.3663: To amend title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies; H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy management, public plan option and pharmacy benefit manager transparency requirements; H.R.3590: An act entitled The Patient Protection and Affordable Care ActDME Accreditation, AMP Fix, PBM Transparency, MTM Expansion, OPM PBA v. PBM; Senator Akaka Amendment to Senate version of H.R. 3590 to establish automatic enrollment into a Medicare Part D "chronic care management" program for targeted individuals; Senator Brown amendment to H.R. 3590 eliminating DMEPOS surety bond requirement for retail pharmacies; Senator Dorgan Drug Reimportation amendment to H.R. 3590; FSA Debit Card Programseeking Congressional support to amend IRS guidance (no legislation).

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Treasury, Dept of

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), pharmacy dispensing fees, privacy, and reimportation. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 3200: America's Affordable Health Choices Act of 2009 HR 3590: The Patient Protection and Affordable Care Act HR 3962: Affordable Health Care for America Act S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act of 2009

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2221, Data Accountability and Trust Act, related to the use of prescription drug data by pharmacies. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. 3108, the Medication Therapy Management Benefits Act, as related to an expanded MTM program in the Medicare Part D program. H.R. 3200, America's Affordable Health Choices Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. H.R. 3590, Patient Protection and Affordable Care Act, as related to the role of pharmacy in healthcare reform, specifically related to Medicare and Medicaid issues. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME Program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically related to Medicare and Medicaid issues. S.1383, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.

Client expense: $450,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

Changes to the Medicare and Medicaid programs, including rebate structures and formularies, coverage, pharmacy reimbursement for generic drugs under Medicaid, disclosure of PBM information and the Medicare DME program. H.R. 3200 Americas Affordable Health Choices Act of 2009; Americas Healthy Future Act of 2009; S. 956/H.R. 1970-Preserve Patient Access to Reputable DMEPOS Providers Act of 2009

Client expense: Not reported · Firm income: $20,000

Government targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE

Health care reform proposals, provisions impacting employers. H1N1 preparedness. H.R. 3200, America's Affordable Health Choices Act of 2009. S. 1679, Affordable Health Choices Act. S. 956/H.R. 1970, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009. H.R. 3108, Medication Therapy Management Benefits Act of 2009.

Client expense: Not reported · Firm income: $100,000

Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT)

IRS regulation of tax preparers, HR 294 (bonding for small veteran owned businesses), HR 3771 (small business assistance), surety bonds for DMEPOS (HR 3200, HR 1970, HR 3663, S 956, S 975), bond requirements in highway reauthorization legislation, Department of Transportation bond premium reimbursement program, SBA Bond Guarantee Program, surety bond for H2A agricultural workers, Customs bonds, administration and processing of DMEPOS bonds

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)

HR 616 and S. 511, Access to Durable Medical Equipment Act, to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applied to certain professionals; exempts pharmacists and pharmacies from accreditation requirements in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies program. House Tri-Committee Health Care Reform Legislation - Discussion Draft, Section 1841, Pages 708 - 710 - AMP Medicaid Reimbursement Formula. HR 1970 - Preserve Patient Access to Reputable DMEPOS Providers Act, support full text. HR 616 - Access to Durable Medical Equipment Act, support full text. S. 511 - Access to Durable Medical Equipment Act, support full text. HR 3663 - Full text- Extension of Medicare DME Accreditation Deadline for Certain Pharmacies. S 956 - Preserve Patient Access to Reputable DMEPOS Providers Act, support full text. Health Information Technology for Economic and Clinical Health Act (HITECH Act) is in the American Recovery and Reinvestment Act (ARRA)- Public Law 111-5. Provided input to HHS as they begin development of regulations to implement the HITECH Act of 2009. Specific areas addressed are Description of Health Care Messaging Programs, Consumer Choice, Transparency of Sponsorship and Discretion. Senate Finance and HELP Committee Health Care Reform Proposals: HELP Section 212; Finance Title II, Subtitle B; Finance Title III, Subtitle A, Part III -Integrated Care Models such as medical homes, accountable care organizations,community health teams, and home-based chronic care programs. HELP Section 216; Finance Title III, Subtitle A, Part III - Transitional Care Activities such as medication reconciliation, medication records,and discharge planning that may include medication therapy management services. HELP Section 213; Finance Title III, Subtitle A, Part III - Grant Programs aimed at evaluating the effectiveness of patient-centered, teambased practice approaches; specifically the programs that support medication therapy management. Finance Title III, Subtitle C - Incentive Programs that provide Medicare Advantage plans incentives to provide robust medication therapy management programs.

Client expense: $1,027,870 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare/Medicaid-Changes to the Medicare and Medicaid programs, including rebate structures and formularies, coverage, pharmacy reimbursement for generic drugs under Medicaid, disclosure of PBM information and the Medicare DME program. H.R. 3200 - America's Affordable Health Choices Act of 2009 America's Healthy Future Act of 2009 S. 956/H.R. 1970-Preserve Patient Access to Reputable DMEPOS Providers Act of 2009

Client expense: $1,950,000 · Firm income: Not reported

Government targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

Client expense: $370,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1548 & S. 1427 - to amend title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes - Average Manufacturer's Price H.R. 616 & S. 511 - to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals H.R. 1970 & S. 956 - to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacists from the surety bond requirement under the Medicare program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS)

Client expense: $1,620,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Energy, Dept of, Environmental Protection Agency (EPA), Federal Energy Regulatory Commission (FERC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

S266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR203 - Medicare Fraud Prevention Act of 2009 HR27 - Medicare Fraud Prevention and Enforcement Act of 2009 Under Line 17: We would like to include the Office of the National Coordinator for Health Information Technology HR616/S511 - Access to Durable Medical Equipment Act HR574/S254 - Medicare Home Infusion Therapy Coverage Act of 2009 HR2560/S1131 - Independence At Home Act HR1970/S956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR3700/S1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturers Price Reimbursement Formula in Health Care Reform HR3108 - Medication Therapy Managament Benefits Act of 2009/Concept to Include Medication Therapy Management Provisions in Health Care Reform HR3663 - Amends the Social Security Act to delay the October 1, 2009 deadline on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies. S683 - Community Choice Act of 2009 HR1392/S1221 - Amends the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 sections on Medicare DMEPOS (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) [Document Number: CMS-10260 (OMB#: 0938-1051)] Collection Activities; Medicare Advantage and Prescription Drug Program: Final Marketing Provisions (74 FR 45206) HRSA Notice Regarding 340B Pricing Program - Children's Hospitals (74 FR 28937) ONC Draft Recommendations for the Term "Meaningful Use" of Electronic Health Records CMS August 2009 Memo: Fraud, Waste and Abuse (FWA) Training Clarification (regarding changes to 42 C.F.R. 422.503(b)(4)(vi) and 42 C.F.R. 423.504 (b)(4)(vi)) Final 2010 Medicare Part D Call Letter

Client expense: $157,696 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, White House Office

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), and pharmacy dispensing fees. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 3108 - To amend part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 3200 -America's Affordable Health Choices Act of 2009 - Title IV Quality, Subtitle E Financing, Sec. 1741 Payments to Pharmacists, (a) Pharmacy Reimbursement Limits; Title II Workforce, Subtitle D Adapting Workforce to Evolving Health System Needs, Part 2 Interdisciplinary Training Programs, Sec. 2252 Innovations In Interdisciplinary Care Training, (b) Training Programs; Title III Promoting Primary Care, Mental Health Services, and Coordinated Care, Sec. 1302 Medical Home Pilot Program, (d) Community-Based Medical Home Model; Title I Improving Health Care Value, Subtitle B Provisions Related to Part B, Part 3 Other Provisions, Sec. 1148. Durable Medical Equipment Program Improvements Americas Healthy Future Act of 2009 - Title I Health Care Coverage, Subtitle G Role of Public Programs, Part V - Medicaid Prescription Drug Coverage, Changes to Medicaid Payment for Prescription Drugs; Title III Improving the Quality and Efficiency of Health Care, Part III Encouraging Development of the New Patient Care Models, CMS Innovation Center; Title III Improving the Quality and Efficiency of Health Care, Subtitle D Improving Payment Accuracy, Durable Medical Equipment S 1679 -Affordable Health Choices Act - Title II Improving the Quality and Efficiency of Health Care, Subtitle A National Strategy to Improve Health Care Quality, Sec. 213 Grants to Implement Medication Management Services in Treatment of Chronic Diseases; Title II - Improving the Quality and Efficiency of Health Care, Subtitle B Health Care Quality Improvements, Sec. 212 Grants to Establish Community Health Teams to Support the Patient-Centered Medical Home HR 3293 - Department of Health and Human Services Appropriations Act of 2010 - proposed inclusion of provisions relating to Durable Medical Equipment

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program issues Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill H.R. 616, S. 511 Pharmacists Exemption to CMS DME Requirements H.R. 1970, S. 956, the Preserve Patient Access to Reputable DMEPOS Providers Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program issues Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill H.R. 616, S. 511 Pharmacists Exemption to CMS DME Requirements H.R. 1970, S. 956, the Preserve Patient Access to Reputable DMEPOS Providers Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program issues Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill H.R. 616, S. 511 Pharmacists Exemption to CMS DME Requirements H.R. 1970, S. 956, the Preserve Patient Access to Reputable DMEPOS Providers Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program issues Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill H.R. 616, S. 511 Pharmacists Exemption to CMS DME Requirements H.R. 1970, S. 956, the Preserve Patient Access to Reputable DMEPOS Providers Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 100th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; (more) Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements and small business tax provisions; H.R. 1166 (E-Fencing Enforcement Act of 2009), H.R. 1173 (Organized Retail Crime Act of 2009) and S. 470 (Combating Organized Retail Crime Act of 2009); H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009; S. 1383, the "Dextromethorphan Abuse Reduction Act; and "H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy management, public plan option and requirements for businesses to provide health insurance, and pharmacy benefit manager transparency requirements.

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. 3108, the Medication Therapy Management Benefits Act, as related to an expanded MTM program in the Medicare Part D program. H.R. 3200, America's Affordable Health Choices Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME Program. S.1383, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.___, Americas Healthy Future Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. Various issues related to the role of pharmacy and pharmacists in healthcare reform, including pharmacy services in the Medicare program.

Client expense: $720,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

Medicare surety bonds for pharmacies (HR 1970, S956 and S975), Bond guarantee and mentoring programs for small businesses, Miller Act surety requirements, Best practices exchange in China regarding licensure for construction companies

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Navy, Dept of, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)

H.R.1/S.350, the American Recovery and Reinvestment Act, related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S.726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R.1359/S.1292, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Part B surety bond requirement. H.R.1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R.3108, the Medication Therapy Management Benefits Act, related to expansion of the Medicare Part D medication therapy management benefit. S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009, as related to the importation of prescription drugs. H.R.1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals. S. 1383, Dextromethorphan Abuse Reduction Act of 2009, as related to the abuse of dextromethorphan. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. The Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement for generic drugs in the Medicaid program. Various issues related to the role of pharmacy and pharmacists in healthcare reform, including pharmacy services in the Medicare program.

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 100th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; (more) Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements and small business tax provisions; H.R. 1166 (E-Fencing Enforcement Act of 2009), H.R. 1173 (Organized Retail Crime Act of 2009) and S. 470 (Combating Organized Retail Crime Act of 2009); H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life savings Medicines Act of 2009"; H.R. 3202, the "Water Protection and Reinvestment Act of 2009"; H.R.2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therpay Benefits Act of 2009"; and "H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; the yet-to-be-released draft Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, public plan option and requirements for businesses to provide health insurance.

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, White House Office

Issues related to the sale of food and drugs, drug safety and drug abuse S. 510 - FDA Food Safety Modernization Act H.R. 2749 - Food Safety Enhancement Act of 2009 S. 1383 - Dextromethorphan Abuse Reduction Act of 2009 H.R. 1970 - Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 S. 956 - Preserve Patient Access to Reputable DMEPOS Providers Act of 2009

Client expense: $2,035,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR616/S511 - Access to Durable Medical Equipment Act HR203 - Medicare Fraud Prevention Act of 2009 HR27 - Medicare Fraud Prevention and Enforcement Act of 2009 HR574 - Medicare Home Infusion Therapy Coverage Act of 2009 S266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR2560/S1131 - Independence At Home Act HR1970/S956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR3700/S1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturer Price Reimbursement Formula in Health Care Reform (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 Sections on Medicare DMEPOS (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Solicitation for Comments on the Draft CMS Model Transition Letter for Calendar Year 2010 Draft 2010 Medicare Part D Call Letter

Client expense: $194,415 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

Client expense: $520,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1548 & S. 1427 to amend title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes Average Manufacturers Price H.R. 616 & S. 511 to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals H.R. 1970 & S. 956 to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS)

Client expense: $2,580,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Energy, Dept of, Federal Energy Regulatory Commission (FERC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

All legislative and executive actions concerning healthcare reform, including provision related to medication therapy management (MTM), average manufacturer's price (AMP), and durable medical equipment (DME). S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 3108 - To amend part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 1256 - To protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products, to amend title 5, United States Code, to make certain modifications in the Thrift Savings Plan, the Civil Service Retirement System, and the Federal Employees' Retirement System, and for other purposes. Amendment offered related to drug reimportation. Affordable Health Choices Act; provisions related to medication therapy management and drug reimportation

Client expense: Not reported · Firm income: $50,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE